Aphria (company)

Canadian cannabis company

For other uses of "Aphria", see Aphria (disambiguation).

Aphria Inc.

Company type| Defunct

Traded as

| NSYE & NASDAQ: APHA
Industry| Cannabis
Founded| 2014
Founders| Cole Cacciavillani
John Cervini
Defunct| 2020
Headquarters|

Leamington, Ontario

Canada

Key people

| Irwin D Simon (Chief Executive Officer)
Revenue| CA$36.9 million (2018)
Parent| Tilray
Website| https://aphria.ca/

Aphria Inc., headquartered in Leamington, Ontario, was an international producer and distributor of medicinal and recreational cannabis. The company operated through retail and wholesale channels in Canada and internationally.

Aphria was a main distributor of medical cannabis to Germany and had operations in 10 additional countries outside of Canada. Aphria offers multiple products under a portfolio of recreational cannabis brands, including Good Supply, B!NGO, Solei, RIFF, and Broken Coast. In November 2020, Aphria acquired SweetWater Brewing Company, one of the largest craft breweries in the USA.

Prior to its acquisition by Tilray, Aphria was one of the largest cannabis companies in the world, and was listed on both the Toronto Stock Exchange and NASDAQ.[1] The merger with Tilray was announced in December 2020, and Aphria now operates under the Tilray name.[2]

## History

[edit]

Aphria was founded in 2013 by Cole Cacciavillani and John Cervini, who were Leamington greenhouse operators.[3] Its CEO for its formative years was Vic Neufeld, formerly the CEO of Jamieson Laboratories, a Canadian vitamin company.[4] It was originally listed on the Toronto Venture Exchange before it was uplisted to the Toronto Stock Exchange in March of 2017, and joined the S&P/TSX Composite Index in December 2017.[5]

In 2014, Health Canada granted Aphria a license to produce and sell medical cannabis.[3] Its first wholesale shipments were in April 2015. Also in April 2015, the company announced it would double the size of its greenhouse space.[6]

In January 2018, Aphria agreed to take over Broken Coast Cannabis, a Vancouver Island based cannabis producer.[7]

In May 2018, Aphria reached a deal with Southern Glazer's Wine & Spirits to distribute Aphria's recreational cannabis products in Canada.[8]

Aphria nominated Irwin D. Simon, previously of The Hain Celestial Group, Inc., as Chair of the Board of Directors and interim CEO in December 2018.[9]

In 2020, the company moved its listing from the New York Stock Exchange to the NASDAQ, citing cost cuts as the reason for the change.[10]

## Tilray merger

[edit]

On 15 December 2020, Aphria conducted a reverse acquisition to merge with Tilray, which would create the largest multinational cannabis company by revenue.[2] The chief executive officer (CEO) of Aphria, Irwin Simon, stated that the merger strategy was to capture Tilray's business assets and public trading exposure in the United States and its free trade abilities in Europe, enabling potential for becoming a global operation.[2] Irwin was named as CEO and chairman of the board for the merged company, and Tilray CEO, Brendan Kennedy, will be a member of the board of directors.[2]

The merged companies will keep Tilray's name and trade under the Tilray ticker symbol, TLRY, on the NASDAQ exchange.[2] By combining assets, the Aphria-Tilray company will develop craft beer and cannabis-infused beverages in partnership with Anheuser-Busch InBev, and have branded hemp and cannabidiol products.[2] According to one source, the world market potential for cannabis products is $94 billion by 2025.[2]

## See also

[edit]

* Cannabis in Canada

## References

[edit]

1. ^ "Change in U.S. marijuana policy casts uncertainty over Canadian industry". The Globe and Mail. Retrieved January 11, 2018.
2. ^ a b c d e f g Kary, Tiffany (December 15, 2020). "Aphria, Tilray combine to create biggest cannabis company". Bloomberg. Retrieved January 15, 2021.
3. ^ a b "The new cash crop". Windsor Star. December 21, 2014. Retrieved January 11, 2018.
4. ^ "From vitamins to pot: A CEO's new growth plan". The Globe and Mail. June 3, 2014. Retrieved January 11, 2018.
5. ^ "Leamington medical pot producer Aphria hits TSX". CBC News. Retrieved January 11, 2018.
6. ^ "Aphria Medical Marijuana to double its Leamington operation". CBC News. April 2, 2015. Retrieved January 11, 2018.
7. ^ "Aphria buying Broken Coast Cannabis for $230M in stock and cash | CBC News". CBC. Retrieved May 9, 2018.
8. ^ "Aphria strikes deal with Southern Glazer's on cannabis distribution - Article - BNN". BNN. May 17, 2018. Retrieved May 20, 2018.
9. ^ Inc, Aphria. "Aphria Appoints Irwin D. Simon as Independent Chair of Board of Directors". www.prnewswire.com. Retrieved May 7, 2019. `{{cite web}}`: `|last=` has generic name (help)
10. ^ "Aphria switches to Nasdaq from NYSE to cut costs". Yahoo Finance Canada. May 26, 2020. Retrieved May 31, 2020.

## External links

[edit]

* Official website